OncoCyte (OCX) Stock Chart & Stock Price History $3.73 +0.54 (+16.96%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OncoCyte Stock Price Performance 5 Day Performance+22.86%1 Month Performance+59.26%3 Month Performance+49.57%6 Month Performance+12.79%Year-To-Date Performance+44.54%1 Year Performance+13.91% Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address OCX Stock Chart for Wednesday, March, 5, 2025 OCX Chart by TradingView OncoCyte Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/04/2025$2.78$3.19+14.75%$3.19$2.63105,518 shs$55.68 million03/03/2025$2.80$2.78-0.71%$2.85$2.60175,481 shs$48.52 million02/28/2025$2.57$2.80+8.95%$2.80$2.52179,389 shs$48.87 million02/27/2025$2.57$2.57$2.60$2.5145,334 shs$44.85 million02/26/2025$2.52$2.57+1.98%$2.70$2.5122,624 shs$44.85 million02/25/2025$2.63$2.52-4.18%$2.60$2.3247,920 shs$43.97 million02/24/2025$2.65$2.63-0.75%$2.68$2.5722,329 shs$45.89 million02/21/2025$2.72$2.65-2.57%$2.79$2.5751,737 shs$46.24 million02/20/2025$2.76$2.72-1.45%$2.85$2.6148,208 shs$47.46 million02/19/2025$2.70$2.76+2.22%$2.84$2.7197,046 shs$48.16 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 02/18/2025$2.56$2.70+5.47%$2.80$2.51107,528 shs$45.44 million02/17/2025$2.56$2.56$2.57$2.3573,907 shs$44.68 million02/14/2025$2.38$2.56+7.56%$2.57$2.3573,907 shs$43.09 million02/13/2025$2.51$2.38-5.18%$2.49$2.21120,921 shs$41.54 million02/12/2025$2.37$2.51+5.91%$2.60$2.30226,614 shs$42.24 million02/11/2025$2.07$2.37+14.49%$2.58$2.07362,186 shs$39.89 million02/10/2025$2.01$2.07+2.99%$2.12$1.9741,876 shs$34.84 million02/07/2025$2.05$2.01-1.95%$2.17$1.9535,367 shs$33.83 million02/06/2025$2.16$2.05-5.09%$2.13$2.0516,472 shs$34.50 million02/05/2025$2.13$2.16+1.41%$2.18$2.0720,808 shs$36.35 million02/04/2025$2.13$2.13$2.29$2.0639,801 shs$35.85 million Related Companies Ocugen Stock Price Chart Inhibrx Stock Price Chart Nanobiotix Stock Price Chart CARGO Therapeutics Stock Price Chart Enanta Pharmaceuticals Stock Price Chart INmune Bio Stock Price Chart Alector Stock Price Chart Protalix BioTherapeutics Stock Price Chart Inhibikase Therapeutics Stock Price Chart Acrivon Therapeutics Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 3/5/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.